Retroperitoneal fibrosis in a patient with Parkinson's disease treated with pergolide.
We describe a 68-year-old patient with Parkinson's disease who developed retroperitoneal fibrosis during pergolide treatment. Because pergolide is an ergot derivative, it could be related to the development of this complication.